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Vesicular stomatitis virus (VSV) was incubated with pyrene dodecanoic acid (P12), a fluorescent derivative of a medium-chain length fatty acid, 
and subjected to irradiation with a long wavelength ultra-violet light source at 366 nm (UVA). This inactivated the virus, resulting in a drastic 
decrease of its infectivity. The virus inactivation was proportional to the concentration of the pyrene-fatty acid, the length of exposure of the virus 
to P12 and the irradiation dose. 
1. INTRODUCTION 
Incubation of cells with various dyes, followed by il- 
lumination with a suitable light source results in a 
photosensitization and consequent cell death. The first 
photosensitizing agent, acridine orange, was discovered 
at the turn of the century [I] and this was followed by 
compounds such as porphyrins, merocyanins and 
phthalocyanins [2-51. 
P 1Zmediated photosensitization on inactivation of an 
enveloped virus. The results indicated that incubation 
of vesicular stomatitis virus (VSV) with P12 followed 
by irradiation with UVA resulted in a loss of infectivity 
of the virus. 
2. MATERIALS AND METHODS 
Some of these compounds were also employed for 
photosensitizing and inactivating viruses [6-lo]. 
Pyrene dodecanoic acid (P12) was purchased from Molecular Pro- 
bes (Junction City, OR, USA). 
In previous experiments we have used lipid-bound 
pyrene as a photosensitizer [11,12]. Thus, administra- 
tion of the fluorescent fatty acid derivative, pyrene 
dodecanoic acid (P12), into hemopoietic cells [ 13-151 
rendered them sensitive to long wavelength ultraviolet 
light at 366 nm (UVA). Since leukemic cells took up and 
metabolized the sensitizing compound to a greater ex- 
tent than their normal counterparts, this procedure 
could be utilized for selective killing of leukemic cells 
[ 161 and might serve for purging of bone marrow deriv- 
ed from patient in remission prior to autologous 
transplantation. In other experiments, Pl2-linked 
sphingomyelin was administered into skin fibroblasts 
derived from normal individuals and patients with 
Niemann-Pick disease. Irradiation of the cells with 
UVA permitted a selective killing of the lipidotic cells 
(manuscript submitted for publication). 
BSC-1 cells, derived from monkey kidney were cultured in Dulbec- 
co modified essential medium (DMEM, Gibco Labs., Grand Island, 
NY) supplemented with 5% fetal calf serum (FCS, Kibbutz Beth 
Haemek, Israel). 
In the present study we have tested the effect of 
Vesicular stomatitis virus (VSV) was multiplied by infecting BSC-1 
cells, the culture medium was harvested, clarified by centrifuging for 
10 min at 10 000 x g and stored at -70°C. The titer of VSV was 
determined either by the standard plaque assay using 50 mm Nunc 
dishes, or by end-point dilution in a 96well plate [17]. In either case, 
BSC-1 confluent monolayers were infected with serial decimal dilu- 
tions of the virus and, following overnight incubation, stained with 
Gentian Violet. In the former assay the number of plaques were 
counted, while in the latter wells were scored and the last viral dilution 
that caused cell death was determined. For studying photosensitiza- 
tion by the pyrene fatty acid, a 1 mM solution of P12 in dimethyl- 
sulfoxide was used as stock solution. The required quantity was 
diluted 1:50 in DMEM-5% FCS, and 50 4 of this solution was mixed 
with 50 4 virus in DMEM-5% FCS and after the indicated incubation 
time irradiated. The virus was irradiated for various intervals using 
2 x 15 tubes emitting at long-wave UVA bands from 320 to 380 nm 
with a peak at 366 nm at an incident radiation intensity of 5 mW/cm2 
(both lamps and radiometer from Vilber-Lourmat, Marne-le-Vallees, 
France). 
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3. RESULTS 
Abbreviations: VSV, vesicular stomatitis virus; P12, 12-(l-pyrene)- 
dodecanoic acid; PFU, plaque forming unit; UVA, long wavelength 
ultraviolet light 
Irradiation of vesicular stomatitis virus, which had 
been incubated with P12, at 366 nm (UVA) resulted in 
a photosensitization-induced decrease in the titer of the 
virus. 
Fig. 1 demonstrates the three basic parameters which 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 9 
Volume 270, number 1,2 FEBS LETTERS September 1990 
LOG[P12.COOH,“M INCUBATION rlMe(min, lRR*DlATlON TIME,rni”, 
Fig. 1. Effect of P12 concentration, incubation and irradiation times 
on inactivation of vesicular stomatitis virus. (A) VSV (50 ~1) in 
medium plus 5% FCS was incubated for 1 h with increasing 
concentrations of P12, diluted in 50 $ phosphate-buffered saline and 
irradiated with UVA for 30 s. The titer is expressed as the logarithm 
of plaque forming units (PFU) per ml. Control virus, that was 
incubated in the absence of P12 prior to irradiation, had a titer of 
10”. (B) VSV (50 ~1) in medium supplemented with 5% FCS was 
incubated with 10 pM P12 in 50 ~1 of the same medium and irradiated 
with UVA for 2 min. (C) VSV (50 cl) in medium plus 5% FCS was 
incubated for 1 h with 10 PM P12 in medium plus 5% FCS and 
irradiated with UVA for various intervals. 
controlled the decrease of the titer of VW, namely: the 
concentration of P12, the length of incubation of the 
virus with P12, and the irradiation dose. 
Fig. lA, which describes the effect of increasing con- 
centrations of P12, demonstrated that at 100 PM P12 a 
0.5min irradiation decreased the titer by 6 logs. Fig. 
lB, which shows the effect of the length of incubation 
with P12 (10 PM) indicated that after 1 h incubation, 
UVA irradiation for 2 min decreased the titer by about 
8 logs. Incubation of virus with P12 without irradiation 
or alternatively irradiation of VSV which has not been 
incubated with P12 had no effect on the titer of the 
virus. 
The effect of the irradiation dose could be modified 
by changing the distance of the UVA source from the 
plate (i.e: the UVA-light flux; data not shown), or the 
length of irradiation. Fig. 1C demonstrates the latter, 
indicating that by increasing the UVA-dose a practically 
complete inactivation of the virus was achieved. 
4. DISCUSSION 
Incubating P12 with cultured eukaryotic cells 
resulted in a penetration of the acid into the plasma 
membrane of the cells, subsequent translocation and in- 
corporation into their neutral- and phospholipids 
[13-151. For studying photosensitization of a virus by 
P12, we selected an enveloped virus (VSV), expecting 
that the pyrene fatty acid- would penetrate into the 
envelope and, via its hydrophobic portion (i.e. the 
10 
pyrene nucleus and methylene groups), remain embed- 
ded in it. Though we have no direct evidence that this 
occurs, the expectation is supported by the increased 
sensitivity to irradiation with increasing concentrations 
of P12 or length of incubation of the latter with the 
virus. Very similar results were obtained in our studies 
of killing of hemopoietic cells by incubation with P12 
and irradiation at 366 nm [ 11,12,16]. 
Following incubation of VSV with P12, illumination 
for 2-3 min with a light source at 366 nm, was sufficient 
to cause a nearly total loss of the infectivity of the virus. 
The titer decreased with increasing concentrations of 
P12 and the length of incubation of the virus with P12 
as well as the irradiation dose. 
The data show that the pyrene fatty acid employed, 
and most probably other pyrene lipids which penetrate 
into the envelope, e.g. P12-sulfatide, [18], can be used 
for photosensitizing and inactivating enveloped viruses. 
It would be of interest o define whether this procedure 
could be useful for sterilization of biological materials, 
i.e., blood products, that may be contaminated by such 
viruses and whether photoinactivated viruses can 
preserve their antigenicity, thus permitting their use as 
vaccines. 
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